PMChek
  • Home
  • About Us
  • Contact Us
  • Blog
  • Drug Shortages
  • Login
PMChek
Drug Shortages
Drug Shortages

Drug Shortages reported to us

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.


Sort By: Date | Name


Drug Shortages

Thursday, July 30, 2026

  • FDA Doxycycline Hyclate Tablet Delayed Release (NDC 00591455022) TEVA PHARMACEUTICALS USA
  • FDA Doxycycline Hyclate Tablet Delayed Release (NDC 00591457560) TEVA PHARMACEUTICALS USA
  • FDA Glycopyrrolate Injection (NDC 63323057802) FRESENIUS KABI USA
  • FDA Glycopyrrolate Injection (NDC 63323057805) FRESENIUS KABI USA
  • FDA Glycopyrrolate Injection (NDC 65219080101) FRESENIUS KABI USA
  • FDA Glycopyrrolate Injection (NDC 63323057801) FRESENIUS KABI USA

Monday, July 27, 2026

  • FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071522) GLAXO SMITH KLINE
  • FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071622) GLAXO SMITH KLINE
  • FDA Fluticasone Propionate and Salmeterol Xinafoate Aerosol Mete (NDC 00173071722) GLAXO SMITH KLINE

Friday, July 24, 2026

  • FDA Lopinavir and Ritonavir Oral Solution (NDC 00074395646) ABBVIE
  • FDA Lopinavir and Ritonavir Tablet (NDC 00074052260) ABBVIE
  • FDA Lopinavir and Ritonavir Tablet (NDC 00074401412) ABBVIE
  • FDA Lopinavir and Ritonavir Tablet (NDC 00074300860) ABBVIE
  • FDA Lopinavir and Ritonavir Tablet (NDC 00074679922) ABBVIE
  • FDA Ritonavir Oral Powder (NDC 00074339930) ABBVIE
  • FDA Ritonavir Tablet (NDC 00074234030) ABBVIE

Thursday, July 23, 2026

  • FDA Aspirin Suppository (NDC 00574703412)
  • FDA Belladonna and Opium Suppository (NDC 00574704504) PADAGIS
  • FDA Belladonna and Opium Suppository (NDC 00574704004) PADAGIS
  • FDA Belladonna and Opium Suppository (NDC 00574704012) PADAGIS
  • FDA Belladonna and Opium Suppository (NDC 00574704512) PADAGIS
  • FDA Bendamustine Hydrochloride Injection Solution (NDC 63459039008) TEVA PHARMACEUTICALS USA
  • FDA Hydrocortisone Acetate Suppository (NDC 00574709312) PADAGIS
  • FDA Hydrocortisone Acetate Suppository (NDC 00574709012) PADAGIS
  • FDA Hydromorphone Hydrochloride Suppository (NDC 00574722406) PADAGIS
  • FDA Morphine Sulfate Suppository (NDC 00574711612) PADAGIS
  • FDA Morphine Sulfate Suppository (NDC 00574711212) PADAGIS
  • FDA Morphine Sulfate Suppository (NDC 00574711412) PADAGIS
  • FDA Morphine Sulfate Suppository (NDC 00574711012) PADAGIS
  • FDA Podophyllum Resin Topical Tincture (NDC 00574060115) PADAGIS
  • FDA Succinylcholine Chloride Injection (NDC 63323094310) FRESENIUS KABI USA

Friday, July 17, 2026

  • FDA Tobramycin Sulfate Injection (NDC 00409357801) HOSPIRA

Tuesday, July 7, 2026

  • FDA Travoprost Ophthalmic Solution (NDC 00378965132) MYLAN
  • FDA Travoprost Ophthalmic Solution (NDC 00378965150) MYLAN

Thursday, July 2, 2026

  • FDA Desflurane Liquid for Inhalation (NDC 00781617286) SANDOZ

Tuesday, June 30, 2026

  • FDA Caspofungin Acetate Injection (NDC 00781342194) SANDOZ
  • FDA Caspofungin Acetate Injection (NDC 00781342394) SANDOZ
  • FDA Daptomycin Injection (NDC 00143937801) HIKMA PHARMACEUTICALS USA
  • FDA Gadobutrol Injection (NDC 65219028107) FRESENIUS KABI USA
  • FDA Gadobutrol Injection (NDC 65219028110) FRESENIUS KABI USA
  • FDA Gadobutrol Injection (NDC 65219028115) FRESENIUS KABI USA
  • FDA Gadobutrol Injection (NDC 65219028102) FRESENIUS KABI USA
  • FDA Gadoterate Meglumine Injection (NDC 65219008210) FRESENIUS KABI USA
  • FDA Gadoterate Meglumine Injection (NDC 65219008620) FRESENIUS KABI USA

Monday, June 29, 2026

  • FDA Oxaliplatin Injection (NDC 25021023320) SAGENT PHARMACEUTICAL
  • FDA Oxaliplatin Injection (NDC 25021023310) SAGENT PHARMACEUTICAL

Wednesday, June 17, 2026

  • FDA Emtricitabine Capsule (NDC 61958060101) GILEAD SCIENCES
  • FDA Emtricitabine Oral Solution (NDC 61958060201) GILEAD SCIENCES

Monday, June 15, 2026

  • FDA Donepezil Hydrochloride; Memantine Hydrochloride Capsule Ext (NDC 69238124803) AMNEAL PHARMACEUTICALS
  • FDA Donepezil Hydrochloride; Memantine Hydrochloride Capsule Ext (NDC 69238124703) AMNEAL PHARMACEUTICALS
  • FDA Lorlatinib Tablet (NDC 00069022703) PFIZER U.S.

Friday, June 12, 2026

  • FDA Ifosfamide Injection (NDC 00338399301) BAXTER HEALTHCARE CORP
  • FDA Ifosfamide Injection (NDC 00143953101) HIKMA PHARMACEUTICALS USA
  • FDA Ifosfamide Injection (NDC 10019092602) BAXTER HEALTHCARE CORPORATION
  • FDA Ifosfamide Injection (NDC 00143953001) HIKMA PHARMACEUTICALS USA
  • FDA Ifosfamide Injection (NDC 63323014210) FRESENIUS KABI USA
  • FDA Ifosfamide Injection (NDC 10019092501) BAXTER HEALTHCARE CORPORATION
  • FDA Ifosfamide Injection (NDC 00338399101) BAXTER HEALTHCARE CORP

Monday, June 8, 2026

  • FDA Dacomitinib Tablet (NDC 00069019730) PFIZER U.S.
  • FDA Dacomitinib Tablet (NDC 00069119830) PFIZER U.S.
  • FDA Dacomitinib Tablet (NDC 00069229930) PFIZER U.S.
  • FDA Leflunomide Tablet (NDC 00088216030) SANOFI-AVENTIS U.S.
  • FDA Leflunomide Tablet (NDC 00955173730) WINTHROP, US
  • FDA Leflunomide Tablet (NDC 00955173530) WINTHROP, US
  • FDA Leflunomide Tablet (NDC 00088216130) SANOFI-AVENTIS U.S.

Friday, June 5, 2026

  • FDA Dexmedetomidine Hydrochloride Injection (NDC 71225012606) SLAYBACK PHARMA
  • FDA Dexmedetomidine Hydrochloride Injection (NDC 71225012605) SLAYBACK PHARMA

Thursday, May 21, 2026

  • FDA Gadoterate Meglumine Injection (NDC 65219008005) FRESENIUS KABI USA
  • FDA Gadoterate Meglumine Injection (NDC 65219008415) FRESENIUS KABI USA

Important:   Items shown in shortage are based on information provided by wholesalers when they list manufacturer out and discontinued items. Items are shown for 60 days from date of initial insertion on this list.

PMChek® | 1306 Oxbridge Dr, Lutz FL 33549
Copyright (C) 2026 PMChek.com
Home, About Us, Contact Us, Privacy